GB1356097A - Mineral salt preparation - Google Patents

Mineral salt preparation

Info

Publication number
GB1356097A
GB1356097A GB905473A GB905473A GB1356097A GB 1356097 A GB1356097 A GB 1356097A GB 905473 A GB905473 A GB 905473A GB 905473 A GB905473 A GB 905473A GB 1356097 A GB1356097 A GB 1356097A
Authority
GB
United Kingdom
Prior art keywords
weight
sodium
parts
magnesium
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB905473A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1356097A publication Critical patent/GB1356097A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1356097 Mineral salt preparations F HOFFMANNLA ROCHE & CO AG 23 Feb 1973 [25 Feb 1972] 9054/73 Heading A5B Mineral salt preparations having delayed electrolyte release for the continuous replacement of mineral salts lost by bodily stress and increased transpiration as well as by the use of diuretics, comprises a matrix suitable for imparting slow-release characteristics and in the form of salts 5 to 80 parts by weight of calcium, 5 to 40 parts by weight of magnesium. 2 to 20 parts by weight of potassium and no sodium of less than 20 parts by weight of sodium; the calcium, magnesium and sodium constituting more than 10% by weight of the preparation. The salts may be the appropriate halides, sulphates, phosphates, glycerophosphates, tartrates, citrates or ascorbates. A preferred preparation contains calcium and magnesium glycerophosphates and sodium and potassium chlorides. The preparations may be administered orally in the form of tablets, drageÚs or capsules and may also contain vitamins C, B 1 and B 6 and/or citric acid. The tablets may have a matrix of natural or synthetic material such as wax, e.g. hardened castor oil.
GB905473A 1972-02-25 1973-02-23 Mineral salt preparation Expired GB1356097A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH272072 1972-02-25

Publications (1)

Publication Number Publication Date
GB1356097A true GB1356097A (en) 1974-06-12

Family

ID=4240086

Family Applications (1)

Application Number Title Priority Date Filing Date
GB905473A Expired GB1356097A (en) 1972-02-25 1973-02-23 Mineral salt preparation

Country Status (14)

Country Link
JP (1) JPS4896717A (en)
AT (1) AT322744B (en)
AU (1) AU451930B2 (en)
BE (1) BE795828A (en)
CA (1) CA1023990A (en)
DE (1) DE2305980A1 (en)
FR (1) FR2173263B1 (en)
GB (1) GB1356097A (en)
IE (1) IE37292B1 (en)
IL (1) IL41412A (en)
IT (1) IT978459B (en)
NL (1) NL7301863A (en)
PH (1) PH10214A (en)
ZA (1) ZA73467B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209668A (en) * 1987-09-11 1989-05-24 Ciba Geigy Ag Oral magnesium and potassium compositions
US4954349A (en) * 1987-09-11 1990-09-04 Ciba-Geigy Corporation Oral magnesium and potassium compositions and use
US5035898A (en) * 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
US8399017B2 (en) 2008-05-20 2013-03-19 Fabienne Joanny Use of a matrix for orally administering sustained release magnesium, and composition containing said matrix
US8529950B2 (en) 2008-05-20 2013-09-10 Fabienne Joanny Magnesium system and use thereof in the cosmetics industry
EP2813217A1 (en) 2013-06-11 2014-12-17 Fabienne Joanny Menvielle-Bourg Composition for oral administration of magnesium, in association with a composition for the treatment of type 2 diabetes and its complications
WO2021138025A1 (en) * 2019-12-30 2021-07-08 Robert Olson Composition and therapy for treatment of gag reflexes

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI834309A (en) * 1983-11-24 1985-05-25 Pharmaconsult Oy SALTBLANDNING.
FI120290B (en) * 1996-12-30 2009-09-15 Mirador Res Oy Ltd A method for preparing seasoning compound, food ingredient, and food compositions that lower serum cholesterol
FR2773955B1 (en) * 1998-01-26 2000-04-07 Sanofi Sa DIETETIC COMPOSITION IN THE FORM OF A SALT SUBSTITUTING TABLE SALT
FR3024019B1 (en) * 2014-07-28 2017-11-24 Yvan Erbs FOOD SUPPLEMENT FOR IMPROVING THE FUNCTIONING OF LIVING CELLS AND ASSOCIATED METHOD

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209668A (en) * 1987-09-11 1989-05-24 Ciba Geigy Ag Oral magnesium and potassium compositions
US4954349A (en) * 1987-09-11 1990-09-04 Ciba-Geigy Corporation Oral magnesium and potassium compositions and use
GB2209668B (en) * 1987-09-11 1991-06-05 Ciba Geigy Ag Oral, sustained-release composition comprising potassium and magnesium
AU619481B2 (en) * 1987-09-11 1992-01-30 Ciba-Geigy Ag Oral magnesium and potassium compositions and use
US5035898A (en) * 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
US8399017B2 (en) 2008-05-20 2013-03-19 Fabienne Joanny Use of a matrix for orally administering sustained release magnesium, and composition containing said matrix
US8529950B2 (en) 2008-05-20 2013-09-10 Fabienne Joanny Magnesium system and use thereof in the cosmetics industry
EP2813217A1 (en) 2013-06-11 2014-12-17 Fabienne Joanny Menvielle-Bourg Composition for oral administration of magnesium, in association with a composition for the treatment of type 2 diabetes and its complications
WO2014198591A1 (en) 2013-06-11 2014-12-18 Fabienne Joanny Menvielle-Bourg Composition for the oral administration of magnesium, in association with a composition for treating type 2 diabetes or the complications thereof
WO2021138025A1 (en) * 2019-12-30 2021-07-08 Robert Olson Composition and therapy for treatment of gag reflexes
US11458162B2 (en) 2019-12-30 2022-10-04 Robert Olson Composition and therapy for treatment of gag reflexes

Also Published As

Publication number Publication date
FR2173263A1 (en) 1973-10-05
DE2305980A1 (en) 1973-08-30
BE795828A (en) 1973-08-23
PH10214A (en) 1976-09-29
NL7301863A (en) 1973-08-28
AU451930B2 (en) 1974-08-22
FR2173263B1 (en) 1975-10-10
AU5145573A (en) 1974-07-25
IE37292L (en) 1973-08-25
ZA73467B (en) 1973-10-31
AT322744B (en) 1975-06-10
IL41412A0 (en) 1973-03-30
CA1023990A (en) 1978-01-10
IE37292B1 (en) 1977-06-22
IT978459B (en) 1974-09-20
JPS4896717A (en) 1973-12-10
IL41412A (en) 1976-04-30

Similar Documents

Publication Publication Date Title
GB1356097A (en) Mineral salt preparation
IL58697A0 (en) Analgesic pharmaceutical compositions in the form of effervescent powders comprising metoclopramide
GB1465347A (en) Composition
EP0237241A3 (en) Calcium supplement compressed tablets
IT1150639B (en) PREPARATION OF STABILIZED INSULINS AND METHOD FOR THEIR PRODUCTION
GB1298494A (en) Phenylethanolamine derivatives
ES8600051A1 (en) Pharmaceutical composition
ATE75941T1 (en) POWDERY HYDROPHILIC THEOPHYLLINE FORMULATION AND PROCESS FOR PRODUCTION.
DE2963990D1 (en) Analgesic tablet and process for its preparation
GB1464200A (en) Pharmaceutical composition
ES8705763A1 (en) Pharmaceutical compositions containing gels.
GB1191246A (en) Vitamin-containing Preparations
GB1422193A (en) Pharmaceutical compositions
GB1403900A (en) Pharmaceutical composition
JPS57152858A (en) Acesulfam containing composition and production thereof
GB1355985A (en) Solid slow release preparation of prolonged action
IE37291L (en) Mineral salt preparation
GB1475611A (en) Process for the production of tablets which are free of lubri cating and mould separating agents
IE34077L (en) Dentifrice compositions
GB1265463A (en)
AR241221A1 (en) Moisturized compositions of hydrateforming phosphates and methods for preparation thereof
National Toxicology Program NTP toxicology and carcinogenesis studies of barium chloride dihydrate (CAS No. 10326-27-9) in F344/N rats and B6C3F1 mice (drinking water studies)
GB1268292A (en) 2-furfurylthioinosine and derivatives thereof
GB1275816A (en) Improvements in or relating to dentifrices
GB1287433A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee